Loading…
Vista Pharmaceuticals (BSE 524711)₹6.69+4.69%Pharmaceuticals
At the end of the Jun 2026 quarter, Vista Pharmaceuticals' shareholders were: promoters 21.23%, DIIs 0.02%, public 78.75%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 14,149 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 29.55% | 27.85% | 27.85% | 21.23% | 21.23% | 21.23% | 21.23% | 21.23% | 21.23% | 21.23% | 21.23% | 21.23% |
| DIIs | 0.03% | 0.03% | 0.03% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Public | 70.42% | 72.12% | 72.12% | 78.75% | 78.75% | 78.75% | 78.75% | 78.75% | 78.75% | 78.75% | 78.75% | 78.75% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 14,245 | 13,903 | 14,010 | 13,877 | 13,908 | 14,081 | 14,153 | 14,056 | 14,007 | 14,075 | 14,149 | 14,149 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Murali Meraga | Public | 14.65% | 0.00 |
| Pavan Sathvik Gilaka | Public | 12.59% | 0.00 |
| Umakanth Katta | Public | 12.21% | 0.00 |
| Vista Pharmaceuticals Inc | Promoter | 10.73% | 0.00 |
| Dhananjaya Alli | Promoter | 4.68% | 0.00 |
| Suresh Gadalay | Public | 4.67% | 0.00 |
| Kamal Gadalay | Public | 3.04% | 0.00 |
| Vasant V Alli | Promoter | 2.61% | 0.00 |
| Chittajallu Naga Keerthi | Public | 2.46% | 0.00 |
| Deepthi Pachipala | Public | 2.46% | 0.00 |
| Keshava Murthy Shiva Shankar | Public | 2.05% | 0.00 |
| Telangana State Industrial Development Corporation Limited | Promoter | 1.21% | 0.00 |
| Rajendar Balakrishna | Public | 1.13% | 0.00 |
| Ramaswamy Reddy Pedinekaluva | Public | 1.10% | 0.00 |
| Padmavathi Alli | Promoter | 0.75% | 0.00 |
| Vamsi V Alli | Promoter | 0.68% | 0.00 |
| Roshni Alli | Promoter | 0.55% | 0.00 |
Promoters held 21.23% of Vista Pharmaceuticals at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 0.02% (unchanged at 0.02% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Vista Pharmaceuticals had 14,149 shareholders at the end of the Jun 2026 quarter, against 14,056 a year earlier.
Murali Meraga (Public) held 14.65% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.